The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
Information source: Sheba Medical Center
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Efficacy; Complications
Intervention: cataract surgery with phacoemulsification (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: Sheba Medical Center Official(s) and/or principal investigator(s):
Ophira Salomon, Study Director, Affiliation: Sheba Medical Center
Overall contact:
Ophira Salomon, MD, Phone: 972-3-5302104, Email: ophiras@sheba.health.gov.il
Summary
To assess the risks of intra- and postoperative bleeding tendency associated with cataract
surgery by phacoemulsification in patients on coumadin and antiaggregant treatments.
Design: Consecutive prospective study.
Clinical Details
Official title: The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
Study design: Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Primary outcome: safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment
Secondary outcome: other complications
Detailed description:
To assess the risks of intra- and postoperative bleeding tendency associated with cataract
surgery by phacoemulsification technique in patients on coumadin and antiaggregant treatment
Design: Consecutive prospective study.
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- patients who give informed consent to participate in the study
Exclusion Criteria:
- single eye complicated cataract
Locations and Contacts
Ophira Salomon, MD, Phone: 972-3-5302104, Email: ophiras@sheba.health.gov.il
Sheba Medical Center, Ramat-Gan, Israel; Recruiting
Irina Barequet, md, Sub-Investigator
Joseph Moisseiev, MD, Sub-Investigator
Additional Information
The safety and efficacy of cataract surgery under coumadin treatment
Starting date: July 2007
Ending date: December 2010
Last updated: July 19, 2009
|
